BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 3530834)

  • 1. Multicentre double-blind clinical trials of ciclopirox olamine cream 1% in the treatment of tinea corporis and tinea cruris.
    Bogaert H; Cordero C; Ollague W; Savin RC; Shalita AR; Zaias N
    J Int Med Res; 1986; 14(4):210-6. PubMed ID: 3530834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ciclopirox olamine lotion 1%: bioequivalence to ciclopirox olamine cream 1% and clinical efficacy in tinea pedis.
    Aly R; Maibach HI; Bagatell FK; Dittmar W; Hänel H; Falanga V; Leyden JJ; Roth HL; Stoughton RB; Willis I
    Clin Ther; 1989; 11(3):290-303. PubMed ID: 2663159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of tinea versicolor with a new antifungal agent, ciclopirox olamine cream 1%.
    Clin Ther; 1985; 7(5):574-83. PubMed ID: 2865009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ciclopirox olamine cream for the treatment of tinea pedis: multicenter, double-blind comparative studies.
    Clin Ther; 1985; 7(4):409-17. PubMed ID: 3893700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new antifungal cream, ciclopirox olamine 1% in the treatment of cutaneous candidosis.
    Clin Ther; 1985; 8(1):41-8. PubMed ID: 2870809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulconazole nitrate cream 1 percent for treating tinea cruris and corporis.
    Tanenbaum L; Taplin D; Lavelle C; Akers WA; Rosenberg MJ; Carmargo G
    Cutis; 1989 Oct; 44(4):344-7. PubMed ID: 2805811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of topical 1% butenafine and 1% clotrimazole in tinea cruris and tinea corporis: a randomized, double-blind trial.
    Singal A; Pandhi D; Agrawal S; Das S
    J Dermatolog Treat; 2005; 16(5-6):331-5. PubMed ID: 16428155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once daily treatment with terbinafine 1% cream (Lamisil) for one week is effective in the treatment of tinea corporis and cruris. A placebo-controlled study.
    Budimulja U; Bramono K; Urip KS; Basuki S; Widodo G; Rapatz G; Paul C
    Mycoses; 2001; 44(7-8):300-6. PubMed ID: 11714065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCH 370 (clotrimazole-betamethasone dipropionate) cream in patients with tinea cruris or tinea corporis.
    Katz HI; Bard J; Cole GW; Fischer S; McCormick GE; Medansky RS; Nesbitt LT; Rex IH
    Cutis; 1984 Aug; 34(2):183-8. PubMed ID: 6383734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-blind, randomized, vehicle-controlled study evaluating the efficacy and safety of naftifine 2% cream in tinea cruris.
    Parish LC; Parish JL; Routh HB; Avakian E; Olayinka B; Pappert EJ; Plaum S; Fleischer AB; Hardas B
    J Drugs Dermatol; 2011 Oct; 10(10):1142-7. PubMed ID: 21968664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciclopirox for the treatment of superficial fungal infections: a review.
    Gupta AK; Skinner AR
    Int J Dermatol; 2003 Sep; 42 Suppl 1():3-9. PubMed ID: 12895181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of clotrimazole. A broad-spectrum antifungal agent.
    Spiekermann PH; Young MD
    Arch Dermatol; 1976 Mar; 112(3):350-2. PubMed ID: 769697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolnaftate (tinactin), a new topical antifungal agent.
    Adam JE; Craig GE
    Can Med Assoc J; 1965 Nov; 93(19):1004-5. PubMed ID: 5319027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative study between terbinafine 1% emulsion-gel versus ketoconazole 2% cream in tinea cruris and tinea corporis.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2000 Mar; 10(2):107-9. PubMed ID: 10694308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, multicenter, double-blind, vehicle-controlled study evaluating the efficacy and safety of luliconazole cream 1% once daily for 7 days in patients aged ≥ 12 years with tinea cruris.
    Jones TM; Jarratt MT; Mendez-Moguel I; Paz N; Grekin SK; Cognata Smith C; Kaur M
    J Drugs Dermatol; 2014 Jan; 13(1):32-8. PubMed ID: 24385117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of Naftifine HCl Cream 2% in the Treatment of Pediatric Subjects With Tinea Corporis.
    Gold M; Dhawan S; Verma A; Kuligowski M; Dobrowski D
    J Drugs Dermatol; 2016 Jun; 15(6):743-8. PubMed ID: 27272083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinea corporis/cruris: new treatment options.
    van Heerden JS; Vismer HF
    Dermatology; 1997; 194 Suppl 1():14-8. PubMed ID: 9154395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily naftifine cream 1% in the treatment of tinea cruris and tinea corporis.
    Jordon RE; Rapini RP; Rex IH; Katz HI; Hickman JG; Bard JW; Medansky RS; Lew-Kaya DA; Sefton J; DeGryse RE
    Int J Dermatol; 1990; 29(6):441-2. PubMed ID: 2397973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of ciclopirox olamine 1% cream with ciclopirox 1%-hydrocortisone acetate 1% cream in the treatment of inflamed superficial mycoses.
    Lassus A; Nolting KS; Savopoulos C
    Clin Ther; 1988; 10(5):594-9. PubMed ID: 2856602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naftifine cream 1% versus econazole cream 1% in the treatment of tinea cruris and tinea corporis.
    Millikan LE; Galen WK; Gewirtzman GB; Horwitz SN; Landow RK; Nesbitt LT; Roth HL; Sefton J; Day RM
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 1):52-6. PubMed ID: 3279083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.